U.S. Congress invites pharmacy benefit managers to third drug pricing hearing

The U.S. Senate Finance Committee has invited executives from five pharmacy benefit managers to testify on April 3 on the rising costs of prescription medicines, in Congress’s latest effort to question industry officials directly over an issue voters consistently cite … Continue reading U.S. Congress invites pharmacy benefit managers to third drug pricing hearing